Eris
- Business
Biocon Biologics: Eris to buy Biocon arm’s brands in Rs 366 crore deal
NEW DELHI: Biocon Biologics (BBL) is divesting its dermatology and nephrology branded formulations business to Eris Lifesciences for Rs 366…
Read More »
NEW DELHI: Biocon Biologics (BBL) is divesting its dermatology and nephrology branded formulations business to Eris Lifesciences for Rs 366…
Read More »